Methamphetamine Toxicities and Clinical Management

Overview

Journal NEJM Evid

Specialty General Medicine

Date 2024 Feb 6

PMID 38320504

Authors

Phillip O Coffin

Leslie W Suen

Affiliations

Soon will be listed here.

Abstract

Methamphetamine Toxicities and Clinical ManagementMethamphetamine increases the release and blocks the uptake of norepinephrine, serotonin, and dopamine. This article reviews the morbidity and mortality associated with methamphetamine use and discusses prevention and treatment strategies.

Citing Articles

Identification of Behavioral, Clinical, and Psychological Antecedents of Acute Stimulant Poisoning: Development and Implementation of a Mixed Methods Psychological Autopsy Study.

Antolin Muniz M, McMahan V, Marti X, Brennan S, Tavasieff S, Rodda L JMIR Form Res. 2025; 9():e64873.

PMID: 39815401 PMC: 11745507. DOI: 10.2196/64873.

A review of methamphetamine use and stroke in the young.

Hemphill K, Tierney S, Tirschwell D, Davis A Front Neurol. 2024; 15:1397677.

PMID: 38721123 PMC: 11076881. DOI: 10.3389/fneur.2024.1397677.

References

Turner C, Chandrakumar D, Rowe C, Santos G, Riley E, Coffin P . Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015. Drug Alcohol Depend. 2018; 185:305-312. PMC: 6474784. DOI: 10.1016/j.drugalcdep.2017.12.030. View

Krinzinger H, Hall C, Groom M, Ansari M, Banaschewski T, Buitelaar J . Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence. Neurosci Biobehav Rev. 2019; 107:945-968. DOI: 10.1016/j.neubiorev.2019.09.023. View

Kolaitis N, Saggar R, De Marco T . Methamphetamine-associated pulmonary arterial hypertension. Curr Opin Pulm Med. 2022; 28(5):352-360. DOI: 10.1097/MCP.0000000000000888. View

Rezaei F, Emami M, Zahed S, Morabbi M, Farahzadi M, Akhondzadeh S . Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial. Daru. 2015; 23:2. PMC: 4298048. DOI: 10.1186/s40199-015-0092-y. View

Coffin P, Santos G, Hern J, Vittinghoff E, Santos D, Matheson T . Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial. Addiction. 2017; 113(2):268-278. PMC: 5760469. DOI: 10.1111/add.13950. View

Hester R, Lee N, Pennay A, Nielsen S, Ferris J . The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. Exp Clin Psychopharmacol. 2010; 18(6):489-97. DOI: 10.1037/a0021791. View

Rezaei F, Ghaderi E, Mardani R, Hamidi S, Hassanzadeh K . Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial. Fundam Clin Pharmacol. 2016; 30(3):282-9. DOI: 10.1111/fcp.12178. View

Moallem N, Courtney K, Ray L . The relationship between impulsivity and methamphetamine use severity in a community sample. Drug Alcohol Depend. 2018; 187:1-7. PMC: 6410745. DOI: 10.1016/j.drugalcdep.2018.01.034. View

Rich K, Solomon D . Medical Complications of Injection Drug Use - Part I. NEJM Evid. 2024; 2(2):EVIDra2200292. DOI: 10.1056/EVIDra2200292. View

10.

Pham D, Addison D, Kayani W, Misra A, Jneid H, Resar J . Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis. Emerg Med J. 2018; 35(9):559-563. PMC: 7529122. DOI: 10.1136/emermed-2017-207065. View

11.

Nikeafshar S, Khazaei A, Tahvilian R . Inhibition of Methamphetamine-Induced Cytotoxicity in the U87-Cell Line by Atorvastatin-Conjugated Carbon Nanotubes. Appl Biochem Biotechnol. 2021; 194(1):479-503. DOI: 10.1007/s12010-021-03667-w. View

12.

Kongsakon R, Papadopoulos K, Saguansiritham R . Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. Int Clin Psychopharmacol. 2005; 20(5):253-6. DOI: 10.1097/01.yic.0000166815.83017.d8. View

13.

McKetin R, Dean O, Baker A, Carter G, Turner A, Kelly P . A potential role for N-acetylcysteine in the management of methamphetamine dependence. Drug Alcohol Rev. 2016; 36(2):153-159. DOI: 10.1111/dar.12414. View

14.

Richards J, Albertson T, Derlet R, Lange R, Olson K, Horowitz B . Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015; 150:1-13. DOI: 10.1016/j.drugalcdep.2015.01.040. View

15.

Marin S, Doyle K, Chang A, Concheiro-Guisan M, Huestis M, Johnson-Davis K . One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. J Anal Toxicol. 2015; 40(1):37-42. PMC: 4731401. DOI: 10.1093/jat/bkv101. View

16.

Lin M, Sambo D, Khoshbouei H . Methamphetamine Regulation of Firing Activity of Dopamine Neurons. J Neurosci. 2016; 36(40):10376-10391. PMC: 5050330. DOI: 10.1523/JNEUROSCI.1392-16.2016. View

17.

Batki S, Harris D . Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Am J Addict. 2005; 13(5):461-70. DOI: 10.1080/10550490490512834. View

18.

Coffin P, Santos G, Hern J, Vittinghoff E, Walker J, Matheson T . Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial. JAMA Psychiatry. 2019; 77(3):246-255. PMC: 6990973. DOI: 10.1001/jamapsychiatry.2019.3655. View

19.

Trivedi M, Walker R, Ling W, Dela Cruz A, Sharma G, Carmody T . Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021; 384(2):140-153. PMC: 8111570. DOI: 10.1056/NEJMoa2020214. View

20.

Mancino M, Gentry B, Feldman Z, Mendelson J, Oliveto A . Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study. Am J Drug Alcohol Abuse. 2011; 37(2):131-6. PMC: 3063384. DOI: 10.3109/00952990.2010.543998. View